1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Regulation

FDA Issues UDI Final Rule, Removes Direct Marking Requirement For Implants

The long-awaited unique device identifier final rule is intended to help FDA, device companies and health care providers track medical devices. The rule addresses many of industry’s concerns with FDA’s initial proposal and was met with general support by companies.

In the much-anticipated FDA unique device identification final rule, the agency addressed many industry concerns with the proposed rule, particularly by eliminating direct part marking requirements for implantable devices and changing the date format for product labeling.

Companies praised the revisions, but also said they would be closely monitoring UDI implementation, which

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation